Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 13:10:49.
doi: 10.3389/fcimb.2020.00049. eCollection 2020.

Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence

Affiliations
Review

Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence

Sean J Judge et al. Front Cell Infect Microbiol. .

Abstract

There is a growing body of literature demonstrating the importance of T cell exhaustion in regulating and shaping immune responses to pathogens and cancer. Simultaneously, the parallel development of therapeutic antibodies targeting inhibitory molecules associated with immune exhaustion (such as PD-1, but also TIGIT, and LAG-3) has led to a revolution in oncology with dramatic benefits in a growing list of solid and hematologic malignancies. Given this success in reinvigorating exhausted T cells and the related anti-tumor effects, there are increasing efforts to apply immune checkpoint blockade to other exhausted immune cells beyond T cells. One approach involves the reinvigoration of "exhausted" NK cells, a non-T, non-B lymphoid cell of the innate immune system. However, in contrast to the more well-defined and established molecular, genetic, and immunophenotypic characteristics of T cell exhaustion, a consensus on the defining functional and phenotypic features of NK "exhaustion" is less clear. As is well-known from T cell biology, separate and distinct molecular and cellular processes including senescence, anergy and exhaustion can lead to diminished immune effector function with different implications for immune regulation and recovery. For NK cells, it is unclear if exhaustion, anergy, and senescence entail separate and distinct entities of dysfunction, though all are typically characterized by decreased effector function or proliferation. In this review, we seek to define these distinct spheres of NK cell dysfunction, analyzing how they have been shown to impact NK biology and clinical applications, and ultimately highlight key characteristics in NK cell function, particularly in relation to the role of "exhaustion."

Keywords: NK cells; NK dysfunction; NK exhaustion; immune dysfunction; natural killer cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed phenotype and functional changes of NK cells under different dysfunctional states. Specific pro-inflammatory mediators associated with SASP in NK cells have not been determined. *IFNγ production has been shown to increase in split anergized NK cells. SASP, senescence-associated secretory phenotype.

Similar articles

Cited by

References

    1. Ahn E., Araki K., Hashimoto M., Li W., Riley J. L., Cheung J., et al. . (2018). Role of PD-1 during effector CD8 T cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 115, 4749–4754. 10.1073/pnas.1718217115 - DOI - PMC - PubMed
    1. Algarra I., Collado A., Garrido F. (1997). Altered MHC class I antigens in tumors. Int. J. Clin. Lab. Res. 27, 95–102. 10.1007/bf02912442 - DOI - PubMed
    1. Alvarez M., Simonetta F., Baker J., Pierini A., Wenokur A. S., Morrison A. R., et al. . (2019). Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway. JCI Insight. 5:127729. 10.1172/jci.insight.127729 - DOI - PMC - PubMed
    1. Ames E., Canter R. J., Grossenbacher S. K., Mac S., Chen M., Smith R. C., et al. . (2015). NK cells preferentially target tumor cells with a cancer stem cell phenotype. J. Immunol. 195, 4010–4019. 10.4049/jimmunol.1500447 - DOI - PMC - PubMed
    1. Arai S., Meagher R., Swearingen M., Myint H., Rich E., Martinson J., et al. . (2008). Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Cytotherapy 10, 625–632. 10.1080/14653240802301872 - DOI - PubMed

Publication types